Navigation Links
Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
Date:6/4/2008

e middle of the night and have difficulty returning to sleep. Transcept is also developing TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. For further information, please visit the Company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill Investors / Media

Director of Communications Stephanie Carrington / Jason Rando

(510) 215-3575 (646) 536-7017 / 7025

scarrington@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... NEW YORK , Aug. 1, 2014 ... Square Capital Management, L.P. today responded to the filing ... AGN ) in California.  The complaint makes baseless ... offer rules.  Allergan,s true purpose in ... shareholders, efforts to call a special meeting.  That purpose ...
(Date:8/1/2014)... Aug. 1, 2014 In the latest call ... sexual dysfunction, more than 60 doctors and leading medical ... letter questioning the Food and Drug Administration,s (FDA) decision ... form of male sexual dysfunction compared with ZERO for ... to act for women by approving the first-ever drug ...
(Date:8/1/2014)... Aug. 1, 2014 In the latest call ... sexual dysfunction, more than 60 doctors and leading medical ... letter questioning the Food and Drug Administration,s (FDA) decision ... form of male sexual dysfunction compared with ZERO for ... to act for women by approving the first-ever drug ...
Breaking Medicine Technology:Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 660+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 360+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3
... Reportlinker.com announces that a new market research report ... Drug Markets in Europe ... and the strategies of major pharmaceutical companies ... in Europe remains problematic for the developers, although ...
... Urban League (NUL) and the League of United Latin American ... negotiations and come to an agreement with Walgreens on new ... Americans, especially in diverse and underserved communities, stand to lose ... In an open letter to Express Scripts, Marc H. ...
Cached Medicine Technology:Orphan Drug Markets in Europe 2Orphan Drug Markets in Europe 3Orphan Drug Markets in Europe 4Orphan Drug Markets in Europe 5Orphan Drug Markets in Europe 6Orphan Drug Markets in Europe 7The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 2The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 3
(Date:8/1/2014)... 2014 The evolving healthcare landscape ... pharmacies. At ThoughtSpot 2014, AmerisourceBergen and Good Neighbor ... and resources to enhance patient care and profitability. ... critical issues to give independent pharmacists the tools ... , ThoughtSpot show attendance experienced a nearly 70% ...
(Date:8/1/2014)... Washington, DC (PRWEB) August 01, 2014 ... Mike Thompson (D-CA), Gregg Harper (R-MS), and Peter ... H.R. 5380, the Medicare Telehealth Parity Act of ... "We fully support this effort to improve healthcare ... Linkous, chief executive officer of ATA. "These cost-saving ...
(Date:8/1/2014)... 2014 On Monday, June 30th, the ... Symposium in San Francisco, CA. Now in its fourth ... Marriott Union Square hotel. , “We are excited about ... speed with ACA compliance issues,” Quirk Healthcare Foundation Executive ... provides attendees guidance with NextGen implementation and use, electronic ...
(Date:8/1/2014)... 2014 (HealthDay News) -- Although many parents worry about their ... common choking hazard: food. Such was the case ... after eating a handful of nuts. "At the time, ... the coughing was related to his illness or choking," recalled ... A cashew had become lodged in his windpipe and had ...
(Date:8/1/2014)... August 01, 2014 Over the ... benefited from innovative technologies that have enabled cosmetic ... patient's tooth color. Moreover, the burgeoning elderly population ... age-related tooth ailments. Due to long-term use of ... individuals have demanded dental fillings, veneers and implants. ...
Breaking Medicine News(10 mins):Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Food Is a Common Choking Hazard for Kids, Doctor Says 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... Flight West (AFW),awarded The Distinguished Pilot award to Oakland ... September 29th. Birely completed,37 Angel Flight West missions over ... in need whose non-emergency health care problems require that,they ... AFW volunteer,pilots, donates the cost of all the missions ...
... and audio web cast on October 9, 2007 --, BELLEVILLE, ON, Oct. 5 /PRNewswire-FirstCall/ - ... Agriculture,(USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine,during a: ... Conference Call & Audio Web Cast ... Tuesday, October 9, 2007 ...
... National Center for Complementary and Alternative Medicine (NCCAM) ... Research on Complementary and Alternative Medicine (CAM) to ... the biological effects of a number of plant-derived ... as dietary supplements, on pancreatic diseases, autoimmune and ...
... oncology tests, SAN DIEGO, Oct. 5 AviaraDx, ... a corporate overview of its molecular,diagnostic test offerings and ... is scheduled for Thursday, November,1st, at 2:30 p.m. in ... Marriott,Del Mar Hotel, 11966 El Camino Real, San Diego, ...
... Texans?, AUSTIN, Texas, Oct. 5 AARP today ... of TXU amounts,to one more backroom deal that ignores ... billion in new debt for a mere,one-time $15 electric ... said Bob Jackson, AARP Texas,state director. "They,ll be the ...
... aren,t consuming recommended levels, experts say , , FRIDAY, Oct. ... officials warned pregnant women to eat no more than ... mercury contamination, many women have been confused, and fish ... says that that warning by the U.S. Food and ...
Cached Medicine News:Health News:Angel Flight West Recognizes Northern California Pilots at AFW 24th Anniversary Awards 2Health News:NCCAM expands Centers of Excellence in CAM research program 2Health News:NCCAM expands Centers of Excellence in CAM research program 3Health News:AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout 2Health News:Fish Safe for Pregnant Women to Eat 2Health News:Fish Safe for Pregnant Women to Eat 3
... offers a complete line of flowmeters, available in oxygen, ... available in a variety of calibrations to best suit ... to the gas in use, the Amvex Flowmeter is ... the U with I. For Power Take-Off add PT ...
... Amvex offers a complete line of flowmeters, available in ... all available in a variety of calibrations to best ... specific to the gas in use, the Amvex Flowmeter ... replace the U with I. For Power Take-Off add ...
... complete line of flowmeters, available in oxygen, air, heliox ... a variety of calibrations to best suit your application. ... gas in use, the Amvex Flowmeter is a user ... with I. For Power Take-Off add PT to the ...
0-3.5 LPM Oxygen Flowmeter with Ohmeda male inlet...
Medicine Products: